A 12 Week Study to Confirm the Effectiveness of 8mg of Fesoterodine Compared to 4mg of Fesoterodine

Clinical trial NCT01302067 · COMPLETED

Trial details

NCT number: NCT01302067
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Overactive Bladder

Start date: 2011-05-01
Primary completion: 2012-11-01
Enrollment: 2012

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.